PRESS RELEASE
FOR
IMMEDIATE RELEASE, December 17, 2003
CONTACT:
Illinois Right
to Life Committee
William Beckman, Executive Director, 312-422-9300
Claimed
Benefits of the Morning-After Pill are Misleading
Yesterday, a Food and Drug Administration (FDA) advisory
panel recommended approval of over-the-counter sales of Plan B, an emergency contraception
drug, also known as the morning-after pill. This
irresponsible vote was 23-4 in favor of risking womens health. Misrepresentations abound, including exaggerated
claims about effectiveness, safety, contraceptive action, potential reduction in unwanted
pregnancies, and who benefits from such availability.
Claims that emergency contraception (EC) is 95% effective
are contradicted even on web sites promoting use of EC.
The Feminist Womens Health Center (FWHC) web site cites 75% effectiveness.
Plan B is claimed to be safe enough to allow
over-the-counter sales when the FWHC web site warns women who experience any of five
symptoms after taking EC to call their clinic immediately.
What clinic will they call when they obtained the drug over-the-counter? The listed symptoms are: abdominal pains (severe),
chest pain or shortness of breath, headaches (severe), eye problems, such as blurred
vision, and severe leg or arm pain or numbness. FWHC
also warns that EC does not protect against sexually transmitted infections.
Dr. Stephen Spaulding identifies the following side effects
of emergency contraception: nausea, vomiting, infertility, ectopic pregnancy, and blood
clot formation. The FDA panels
viewpoint that Plan B has an acceptable margin of safety is clearly in
dispute. Safety claims are based on a study
of Plan B usage for nine months, but no studies have been done on either long-term health
effects or impact on the health of teenage girls as they become adults.
Promoters of EC claim it is a contraceptive rather than an
abortifacient. To make this claim, they
needed to move the beginning of life from fertilization to implantation. This redefinition is biological heresy.
Barr Laboratories, soon to be owner of Plan B, claims that
its use will reduce unintended pregnancies by 50%, leading to a substantial reduction in
abortions. IRLC predicts such reductions will
not be achieved because Plan B availability over-the-counter will encourage an increase in
casual sex, especially among teenagers.
An expanding customer base and easy access to Plan B will be
a great benefit to Barr Laboratories profit margin.
Barr can even seek new markets to respond to the negative health consequences that
users of Plan B will suffer in the future. The
benefit to women from over-the-counter sales of Plan B will be new uncharted
health risks, again making women the victims of dangerous drug side effects to support
mens sexual adventures. FDA approval of
over-the-counter sales of Plan B would be a grossly irresponsible action that places
higher priority on casual sex ideology and profit for Barr Laboratories at the expense of
womens health.
William
Beckman
Executive Director
Illinois Right to Life Committee
65 E. Wacker Place, Suite 800
Chicago, IL 60601
312-422-9300
www.illinoisrighttolife.org
beckman@illinoisrighttolife.org
* * * * * * * *
Illinois
Right to Life Committee, founded in 1968, is the oldest Pro-Life educational organization
in Illinois.
|